ClinicalThought

Share

Program Content

Activities

  • Rova-T in Advanced SCLC
    The Premise and Promise of Rovalpituzumab Tesirine, a New Antibody–Drug Conjugate, in Small-Cell Lung Cancer
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 03, 2017

    Expires: November 02, 2018

  • Nivolumab ± Ipilimumab in Advanced SCLC
    Immunotherapy: An Intriguing Work in Progress for the Treatment of Advanced SCLC
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

Faculty

cover img faculity

Daniel Morgensztern, MD

Assistant Professor
Division of Oncology
Department of Medicine
Washington University
St Louis, Missouri

Provided by

ProCE Banner

Supporters

AbbVie

Bristol Myers Squibb